**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 95-11-4 |5-Norbornene-2-carbonitrile, mixture o| 98 | 202-391-5 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XN
Risk Phrases: 20/21/22
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed.The
toxicological properties of this material have not been fully
investigated.
Potential Health Effects
Eye:
May cause eye irritation. May cause chemical conjunctivitis and
corneal damage.
Skin:
May be metabolized to cyanide which in turn acts by inhibiting
cytochrome oxidase impairing cellular respiration. May cause
irritation and dermatitis. May cause cyanosis of the extremities.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea. Metabolism may release cyanide, which may result in
headache, dizziness, weakness, collapse, unconsciousness and
possible death.
Inhalation:
Aspiration may lead to pulmonary edema. May be metabolized to
cyanide which in turns act by inhibiting cytochrome oxidase
impairing cellular respiration. Inhalation at high concentrations
may cause CNS depression and asphixiation.
Chronic:
Effects may be delayed.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid immediately. Do NOT induce vomiting. If conscious and alert,
rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid. Do NOT use mouth-to-mouth
resuscitation.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Will burn
if involved in a fire. Use water spray to keep fire-exposed
containers cool. Combustible liquid. Vapors may be heavier than air.
They can spread along the ground and collect in low or confined
areas. Containers may explode when heated.
Extinguishing Media:
In case of fire, use water, dry chemical, chemical foam, or
alcohol-resistant foam. Use water spray to cool fire-exposed
containers. Water may be ineffective.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth),
then place in suitable container. Avoid runoff into storm sewers and
ditches which lead to waterways. Remove all sources of ignition. Use
a spark-proof tool.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Avoid contact with eyes, skin, and clothing. Empty
containers retain product residue, (liquid and/or vapor), and can be
dangerous. Keep away from heat, sparks and flame. Avoid ingestion
and inhalation. Use only in a chemical fume hood. Do not pressurize,
cut, weld, braze, solder, drill, grind, or expose empty containers to
heat, sparks or open flames.
Storage:
Keep away from heat, sparks, and flame. Store in a tightly closed
container. Store in a cool, dry, well-ventilated area away from
incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate general or
local explosion-proof ventilation to keep airborne levels to
acceptable levels.
Exposure Limits
CAS# 95-11-4:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Clear liquid
Color: colorless
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 82 - 86 deg C @ 10mmHg
Freezing/Melting Point: 12 - 14 deg C
Autoignition Temperature: Not applicable.
Flash Point: 65 deg C ( 149.00 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: Not available.
Solubility in water: Not available.
Specific Gravity/Density: Not available.
Molecular Formula: C8H9N
Molecular Weight: 119.17
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, ignition sources, excess heat.
Incompatibilities with Other Materials:
Oxidizing agents
Hazardous Decomposition Products:
Carbon monoxide, oxides of nitrogen, irritating and toxic fumes and
gases, carbon dioxide.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 95-11-4: RB7930000
LD50/LC50:
Not available.
Carcinogenicity:
5-Norbornene-2-carbonitrile, mixture of endo and exo -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
Safety Phrases:
S 36/37 Wear suitable protective clothing and
gloves.
WGK (Water Danger/Protection)
CAS# 95-11-4: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 95-11-4 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 95-11-4 is not listed on the TSCA inventory.
It is for research and development use only.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 9/02/1997 Revision #5 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Niobocene dichloride
| 12793-14-5 |
|
4,4-Diethoxy-2-butyn-1-al, 97+% (GC)
| 74149-25-0 |
|
Beta-(1,4)-2-Amino-2-Deoxy-D-Glucose
| 9012-76-4 |
|
9,10-Anthracenedicarbonitrile, 99% (UV-Vis)
| 1217-45-4 |
|
alpha-Hydroxyacetophenone, 97%
| 582-24-1 |
|
Cyclopentyl chloride, 99+%
| 930-28-9 |
|
5'-O-Dimethoxytrityl-N-Benzoyl-Desoxycyti-Dine
| 67219-55-0 |
|
4,4,4-Trifluoro-1-phenyl-1,3-butanedione
| 326-06-7 |
|
6-Ethyl-O-Toluidine, 98+%
| 24549-06-2 |
|
2-Phenylindolizine, 99+%
| 25379-20-8 |
|
2-Methyl-3-Buten-2-Ol, 97%
| 115-18-4 |
|
1,3,5-Triacetylbenzene, 98%
| 779-90-8 |
|
Propylamine Hydrochloride, 99+%
| 556-53-6 |
|
3,5-Dinitrosalicylic Acid, 98%
| 609-99-4 |
|
2-Methyl-3-Butyn-2-Ol, 98%
| 115-19-5 |
|
Coumarin 307, laser grade, 98% (uv-vis)
| 55804-70-1 |
|
Calcium Fluoride, 99.99%
| 7789-75-5 |
|
1,3-Dichloro-2-propanol, 99%
| 96-23-1 |
|
1,2:3,5-Di-O-Isopropylidene-Alpha-D-Xylofuranose, 98%
| 20881-04-3 |
|
3,5-Dimethoxybenzoyl chloride, ca. 92%, balance is corresponding acid
| 17213-57-9 |
|
(-)-alpha-Pinene, 98%
| 7785-26-4 |
|
2-Methyl-3-pentanol, 99+%
| 565-62-8 |
|
Mem Chloride, 94-98%(GC)
| 3970-21-6 |
|
Ethyl Crotonate, 96%
| 623-70-1 |
|
2,4-Dinitrophenol, moistened with up to 35% water
| 51-28-5 |
|
2-(Phenylthio)Ethanol, 99%
| 699-12-7 |
|
1-Anthraquinonesulfonic Acid Sodium Salt (Pract), Containing up to
| 128-56-3 |
|
4-(4-Biphenylyl)-2-Methylthiazole, 97%
| 24864-19-5 |
|
4,4'-Dithiodipyridine, 98%
| 2645-22-9 |
|
1-Pentanethiol, 98%
| 110-66-7 |
|
3-Methylsulphonylbenzoic Acid, 95+%
| 5345-27-7 |
|
Hexyl sodium sulfate, pract., 98%
| 2207-98-9 |
|
3-Benzyloxybenzaldehyde,98%
| 1700-37-4 |
|
(s)-3-Butene-1,2-diol, 99% (gc)
| 62214-39-5 |
|
N,N-Dibenzylhydroxylamine, 98%
| 621-07-8 |
|
5-Iodosalicylic acid, 97%
| 119-30-2 |
|
1-Adamantyl methyl ketone, 99%
| 1660-04-4 |
|
6-Bromo-2-Naphthol, 97%
| 15231-91-1 |
|
Furoin, 98%
| 552-86-3 |
|
Iminostilbene, 97%
| 256-96-2 |
|
(+/-)-Citronellic Acid
| 502-47-6 |
|
1-Ethylpyridinium Bromide, 98%
| 1906-79-2 |
|
5-Norbornene-2-carbonitrile, 98% mixture of endo and exo
| 95-11-4 |
|
Isosorbide-5-Mononitrate, CHR
| 16051-77-7 |
|
2,2,4,5,5-Pentamethyl-3-Imidazoline-3-Oxide-1-Oxyl, Free Radical
| 18796-04-8 |
|
Undecylenic aldehyde, 97%
| 112-45-8 |
|
Lumazine, 98%
| 487-21-8 |
|
3-Fluorobenzoic Acid, 99%
| 455-38-9 |
|
2-(Bromomethyl)-Naphthalene, 96%
| 939-26-4 |
|
2,4-Dihydroxy-5,6-Dimethylpyrimidine 97%
| 26305-13-5 |
|
|